A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

Peer Review reports

Original Submission
16 Aug 2021	Submitted	Original manuscript
27 Feb 2022	Reviewed	Reviewer Report - Antonio Pontoriero
21 Apr 2022	Reviewed	Reviewer Report
24 May 2022	Author responded	Author comments - Yun Guan
Resubmission - Version 2
24 May 2022	Submitted	Manuscript version 2
23 Jun 2022	Author responded	Author comments - Yun Guan
Resubmission - Version 3
23 Jun 2022	Submitted	Manuscript version 3
14 Jul 2022	Author responded	Author comments - Yun Guan
Resubmission - Version 4
14 Jul 2022	Submitted	Manuscript version 4
Publishing
20 Jul 2022	Editorially accepted
29 Jul 2022	Article published	10.1186/s12885-022-09914-5

Back to article page